Latest Funding Agreements News

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.

VIP Gloves Limited reports a sharp decline in quarterly sales receipts as it invests heavily in restarting manufacturing operations, while legal proceedings continue to loom.